BioStock: CLS’ partner initiates full market release in the US

CLS’ commercial partner ClearPoint Neuro has initiated its full market release of the ClearPoint Prism 3T Neuro Laser Therapy System, which is based on CLS’ technology. The launch took place June 1-4 at the 2024 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting in Nashville. 

Read the full article at biostock.se:

https://www.biostock.se/en/2024/06/cls-partner-initiates-full-market-release-in-the-us/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se